Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04994249 · ClinicalTrials.gov registry record
Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation
A clinical trial of Pain and Pain, Chronic, sponsored by Stanford University.
- Active
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT04994249: Active study of Pain and Pain, Chronic, sponsored by Stanford University.
NCT04994249 is a study of Pain and Pain, Chronic that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 250 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04994249, a study of Pain and Pain, Chronic, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
To identify diagnostic and prognostic biomarker signatures of recovery versus having persisting high-impact chronic pain and functional disability in adults with Chronic Musculoskeletal Pain.
Primary Outcome
Pain Interference using Patient-Reported Outcome Measurement Information System (PROMIS)-Pain Interference on a T score (mean: 50; standard deviation: 10) and Graded Chronic Pain Scale (GCPS)
Conditions Studied
Study Locations (1)
California
- Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2022-03-21 |
| Est. Completion | 2027-12-31 |
What the registry record for NCT04994249 still lists
NCT04994249 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (18% lower).
The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 0 interventions.
NCT04994249 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04994249 about?
NCT04994249 is a clinical study titled "Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation". To identify diagnostic and prognostic biomarker signatures of recovery versus having persisting high-impact chronic pain and functional disability in adults with Chronic Musculoskeletal Pain.
What is the current status of trial NCT04994249?
This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2022-03-21. Estimated completion is 2027-12-31.
What conditions does trial NCT04994249 study?
This clinical trial studies the following conditions: Pain, Pain, Chronic, Chronic Musculoskeletal Pain, Joint Pain.
Who is sponsoring clinical trial NCT04994249?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04994249 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04994249's enrollment target sits among peer trials
250 70th of 374 higher than 303 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
Pain With Dementia
RECRUITING · NA
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Defense and Veterans Center for Integrative Pain Management (DVCIPM) Pain Registry Biobank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI